Tenofovir poses risk with didanosine

AIDS Patient Care STDS. 2003 Jun;17(6):309. doi: 10.1089/108729103322108184.
No abstract available

Publication types

  • Clinical Trial
  • News

MeSH terms

  • Adenine / adverse effects*
  • Adenine / analogs & derivatives*
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / adverse effects
  • Contraindications
  • Didanosine / administration & dosage
  • Didanosine / blood*
  • Drug Administration Schedule
  • Humans
  • Organophosphonates*
  • Organophosphorus Compounds / adverse effects*
  • Pancreatitis / chemically induced
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Organophosphorus Compounds
  • Tenofovir
  • Adenine
  • Didanosine